KKR to invest about $150 million in India's Gland Pharma-sources

MUMBAI (Reuters) - U.S. private equity firm KKR & Co LP will pay about $150 million for close to 30 percent of India's Gland Pharma Ltd, two sources with direct knowledge of the matter told Reuters. A deal is likely to be announced in the coming weeks, one of the sources said on Friday. KKR India Chief Executive Sanjay Nayar declined to comment, while Gland Pharma Vice Chairman Ravi Penmetsa was not immediately available for comment. The deal would be KKR's second sizeable India investment in six months. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/kkr-invest-150-million-indias-gland-pharma-sources-065657829--sector.html